Annual Current Assets
$2.58 B
+$21.47 M+0.84%
31 December 2023
Summary:
Sarepta Therapeutics annual total current assets is currently $2.58 billion, with the most recent change of +$21.47 million (+0.84%) on 31 December 2023. During the last 3 years, it has fallen by -$24.77 million (-0.95%). SRPT annual current assets is now -0.95% below its all-time high of $2.60 billion, reached on 31 December 2021.SRPT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$2.69 B
+$1.73 M+0.06%
30 September 2024
Summary:
Sarepta Therapeutics quarterly total current assets is currently $2.69 billion, with the most recent change of +$1.73 million (+0.06%) on 30 September 2024. Over the past year, it has increased by +$106.04 million (+4.11%). SRPT quarterly current assets is now at all-time high.SRPT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +4.1% |
| 3 y3 years | -0.9% | +3.1% |
| 5 y5 years | +75.6% | +82.8% |
SRPT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.9% | +0.8% | at high | +9.6% |
| 5 y | 5 years | -0.9% | +75.6% | at high | +82.8% |
| alltime | all time | -0.9% | >+9999.0% | at high | >+9999.0% |
Sarepta Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.69 B(+0.1%) |
| June 2024 | - | $2.68 B(+8.9%) |
| Mar 2024 | - | $2.46 B(-4.4%) |
| Dec 2023 | $685.25 M(+20.1%) | $2.58 B(+5.2%) |
| Sept 2023 | - | $2.45 B(-0.9%) |
| June 2023 | - | $2.47 B(-0.6%) |
| Mar 2023 | - | $2.49 B(-2.7%) |
| Dec 2022 | $570.50 M(+4.9%) | $2.56 B(-2.6%) |
| Sept 2022 | - | $2.63 B(+6.3%) |
| June 2022 | - | $2.47 B(-2.4%) |
| Mar 2022 | - | $2.53 B(-2.8%) |
| Dec 2021 | $543.88 M(+8.9%) | $2.60 B(+19.2%) |
| Sept 2021 | - | $2.19 B(-3.5%) |
| June 2021 | - | $2.27 B(-0.3%) |
| Mar 2021 | - | $2.27 B(-8.6%) |
| Dec 2020 | $499.52 M(+41.1%) | $2.49 B(+7.0%) |
| Sept 2020 | - | $2.32 B(-5.6%) |
| June 2020 | - | $2.46 B(-3.5%) |
| Mar 2020 | - | $2.55 B(+73.4%) |
| Dec 2019 | $353.91 M(+63.9%) | $1.47 B(+7.8%) |
| Sept 2019 | - | $1.36 B(-4.6%) |
| June 2019 | - | $1.43 B(-14.6%) |
| Mar 2019 | - | $1.67 B(+17.2%) |
| Dec 2018 | $215.89 M(+172.2%) | $1.43 B(+40.9%) |
| Sept 2018 | - | $1.01 B(-11.2%) |
| June 2018 | - | $1.14 B(-6.6%) |
| Mar 2018 | - | $1.22 B(-0.8%) |
| Dec 2017 | $79.32 M(+56.7%) | $1.23 B(+67.0%) |
| Sept 2017 | - | $735.61 M(+88.3%) |
| June 2017 | - | $390.58 M(-14.6%) |
| Mar 2017 | - | $457.31 M(+22.4%) |
| Dec 2016 | $50.63 M(+2.8%) | $373.48 M(-14.1%) |
| Sept 2016 | - | $434.74 M(+183.8%) |
| June 2016 | - | $153.19 M(-4.7%) |
| Mar 2016 | - | $160.73 M(-28.4%) |
| Dec 2015 | $49.24 M(+4.2%) | $224.54 M(+83.9%) |
| Sept 2015 | - | $122.11 M(-33.1%) |
| June 2015 | - | $182.39 M(-5.5%) |
| Mar 2015 | - | $193.05 M(-22.1%) |
| Dec 2014 | $47.24 M(+127.5%) | $247.80 M(-8.2%) |
| Sept 2014 | - | $269.81 M(-11.4%) |
| June 2014 | - | $304.67 M(+22.2%) |
| Mar 2014 | - | $249.37 M(-7.9%) |
| Dec 2013 | $20.76 M(+87.3%) | $270.81 M(-6.8%) |
| Sept 2013 | - | $290.42 M(+68.0%) |
| June 2013 | - | $172.91 M(-2.1%) |
| Mar 2013 | - | $176.59 M(-8.9%) |
| Dec 2012 | $11.09 M(+20.7%) | $193.91 M(+359.9%) |
| Sept 2012 | - | $42.16 M(+26.9%) |
| June 2012 | - | $33.23 M(-11.7%) |
| Mar 2012 | - | $37.63 M(-16.7%) |
| Dec 2011 | $9.18 M(+12.9%) | $45.18 M(-13.0%) |
| Sept 2011 | - | $51.95 M(-21.3%) |
| June 2011 | - | $66.02 M(+71.5%) |
| Mar 2011 | - | $38.49 M(+1.7%) |
| Dec 2010 | $8.14 M | $37.84 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $42.31 M(+6.0%) |
| June 2010 | - | $39.93 M(-9.6%) |
| Mar 2010 | - | $44.15 M(-14.0%) |
| Dec 2009 | $8.72 M(+2.6%) | $51.31 M(-9.9%) |
| Sept 2009 | - | $56.95 M(+134.1%) |
| June 2009 | - | $24.33 M(-15.5%) |
| Mar 2009 | - | $28.78 M(+68.9%) |
| Dec 2008 | $8.49 M(-14.5%) | $17.04 M(-13.3%) |
| Sept 2008 | - | $19.66 M(-12.8%) |
| June 2008 | - | $22.55 M(-11.1%) |
| Mar 2008 | - | $25.36 M(-11.7%) |
| Dec 2007 | $9.93 M(+43.4%) | $28.71 M(+71.4%) |
| Sept 2007 | - | $16.75 M(-21.0%) |
| June 2007 | - | $21.22 M(-25.1%) |
| Mar 2007 | - | $28.31 M(-16.6%) |
| Dec 2006 | $6.92 M(-10.7%) | $33.94 M(-13.6%) |
| Sept 2006 | - | $39.29 M(-12.9%) |
| June 2006 | - | $45.10 M(-11.2%) |
| Mar 2006 | - | $50.77 M(+4.3%) |
| Dec 2005 | $7.75 M(-6.8%) | $48.65 M(+54.5%) |
| Sept 2005 | - | $31.50 M(-2.9%) |
| June 2005 | - | $32.43 M(-13.5%) |
| Mar 2005 | - | $37.47 M(+85.5%) |
| Dec 2004 | $8.32 M(-5.0%) | $20.20 M(-15.1%) |
| Sept 2004 | - | $23.80 M(-19.7%) |
| June 2004 | - | $29.65 M(-20.2%) |
| Mar 2004 | - | $37.16 M(-3.2%) |
| Dec 2003 | $8.75 M(+6.7%) | $38.39 M(+35.6%) |
| Sept 2003 | - | $28.31 M(-8.0%) |
| June 2003 | - | $30.78 M(+144.6%) |
| Mar 2003 | - | $12.58 M(-38.3%) |
| Dec 2002 | $8.20 M(+30.1%) | $20.40 M(-11.4%) |
| Sept 2002 | - | $23.03 M(-23.9%) |
| June 2002 | - | $30.27 M(-20.6%) |
| Mar 2002 | - | $38.10 M(+38.5%) |
| Dec 2001 | $6.30 M(+222.1%) | $27.51 M(-4.5%) |
| Sept 2001 | - | $28.82 M(-19.6%) |
| June 2001 | - | $35.86 M(+30.5%) |
| Mar 2001 | - | $27.48 M(-17.1%) |
| Dec 2000 | $1.96 M(+63.1%) | $33.13 M(-13.4%) |
| Sept 2000 | - | $38.27 M(+261.1%) |
| June 2000 | - | $10.60 M(-26.6%) |
| Mar 2000 | - | $14.43 M(+23.3%) |
| Dec 1999 | $1.20 M(0.0%) | $11.70 M(+368.0%) |
| Sept 1999 | - | $2.50 M(-43.2%) |
| June 1999 | - | $4.40 M(-34.3%) |
| Mar 1999 | - | $6.70 M(-25.6%) |
| Dec 1998 | $1.20 M(+9.1%) | $9.00 M(-21.7%) |
| Sept 1998 | - | $11.50 M(-20.7%) |
| June 1998 | - | $14.50 M(-11.0%) |
| Mar 1998 | - | $16.30 M(-7.9%) |
| Dec 1997 | $1.10 M(-8.3%) | $17.70 M(-4.3%) |
| Sept 1997 | - | $18.50 M(+5.1%) |
| June 1997 | - | $17.60 M(+665.2%) |
| Mar 1997 | - | $2.30 M |
| Dec 1996 | $1.20 M | - |
FAQ
- What is Sarepta Therapeutics annual total current assets?
- What is the all time high annual current assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly current assets year-on-year change?
What is Sarepta Therapeutics annual total current assets?
The current annual current assets of SRPT is $2.58 B
What is the all time high annual current assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total current assets is $2.60 B
What is Sarepta Therapeutics quarterly total current assets?
The current quarterly current assets of SRPT is $2.69 B
What is the all time high quarterly current assets for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total current assets is $2.69 B
What is Sarepta Therapeutics quarterly current assets year-on-year change?
Over the past year, SRPT quarterly total current assets has changed by +$106.04 M (+4.11%)